Your browser doesn't support javascript.
loading
Efficacy of imiquimod in the management of lentigo maligna.
Daude, Marie; Dinulescu, Monica; Nguyen, Jean-Michel; Maillard, Hervé; Le Duff, Florence; Machet, Laurent; Beylot-Barry, Marie; Legoupil, Delphine; Wierzbicka-Hainaut, Ewa; Bedane, Christophe; Leccia, Marie Thérèse; Debarbieux, Sébastien; Meyer, Nicolas; Monestier, Sandrine; Bens, Guido; Denis, Marc G; Bossard, Celine; Vergier, Beatrice; Khammari, Amir; Dréno, Brigitte.
Afiliación
  • Daude M; Nantes Université, INSERM, CNRS, CHU Nantes, Immunology and New Concepts in ImmunoTherapy, INCIT, UMR 1302/EMR6001, Nantes, France.
  • Dinulescu M; Department of Dermatology, CHU Rennes, Rennes, France.
  • Nguyen JM; Biostatistics and Epidemiology, Hôpital Saint Jacques - CHU Nantes, Nantes, France.
  • Maillard H; Department of Dermatology, CH Le Mans, Le Mans, France.
  • Le Duff F; Department of Dermatology, CHU Nice, Centre de recherche Clinique, Nice, France.
  • Machet L; Department of Dermatology, CHU Tours, Tours, France.
  • Beylot-Barry M; Department of Dermatology, CHU Bordeaux, Bordeaux, France.
  • Legoupil D; Department of Dermatology, CHU Brest, Brest, France.
  • Wierzbicka-Hainaut E; Department of Dermatology, CHU Poitiers, Poitiers, France.
  • Bedane C; Department of Dermatology, CHU Limoges, Limoges, France.
  • Leccia MT; Department of Dermatology, CHU Grenoble, Grenoble, France.
  • Debarbieux S; Department of Dermatology, Hospices Civiles de Lyon, Hôpital Lyon Sud, Pierre Bénite, France.
  • Meyer N; Department of Dermatology, CHU Toulouse, Toulouse, France.
  • Monestier S; Department of Dermatology, CHU Marseille, Marseille, France.
  • Bens G; Department of Dermatology, CHU Orléans, Orléans, France.
  • Denis MG; Nantes Université, INSERM, CNRS, CHU Nantes, Immunology and New Concepts in ImmunoTherapy, INCIT, UMR 1302/EMR6001, Nantes, France.
  • Bossard C; Department of CHU Nantes, CRCINA, Nantes, France.
  • Vergier B; Department of Pathology, CHU Bordeaux, Pessac, France.
  • Khammari A; Department of Dermatology, Nantes Université, Univ Angers, CHU Nantes, CIC 1413, INSERM, CNRS, Immunology and New Concepts in ImmunoTherapy, INCIT, UMR 1302, Nantes, France.
  • Dréno B; Nantes Université, INSERM, CNRS, CHU Nantes, Immunology and New Concepts in ImmunoTherapy, INCIT, UMR 1302/EMR6001, Nantes, France.
J Eur Acad Dermatol Venereol ; 37(9): 1785-1791, 2023 Sep.
Article en En | MEDLINE | ID: mdl-37114291
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Peca Melanótica de Hutchinson / Antineoplásicos Tipo de estudio: Clinical_trials / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Eur Acad Dermatol Venereol Asunto de la revista: DERMATOLOGIA / DOENCAS SEXUALMENTE TRANSMISSIVEIS Año: 2023 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Peca Melanótica de Hutchinson / Antineoplásicos Tipo de estudio: Clinical_trials / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Eur Acad Dermatol Venereol Asunto de la revista: DERMATOLOGIA / DOENCAS SEXUALMENTE TRANSMISSIVEIS Año: 2023 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Reino Unido